BPC-157 Cost: Price Breakdown & What to Expect
BPC-157 isn't commercially available yet. Here's what research-grade pricing looks like today, and what to expect when it gets approved.
Not yet commercially available. Pricing estimates are based on comparable drugs and research-grade market rates.
Current Research-Grade Pricing
Research peptide suppliers sell BPC-157 for laboratory use only (not for human consumption). Prices vary by vial size and vendor:
| Vial Size | Typical Price Range | Notes |
|---|---|---|
| 2mg | $60–$120 | Entry-level vial, good for verifying source quality |
| 5mg | $100–$180 | Most common vial size for research |
| 10mg | $150–$300 | Better value per mg; verify COA before purchasing |
| 15mg | $200–$400 | Bulk pricing; limit to verified vendors only |
Prices sourced from publicly available research peptide vendor listings. These products are for research use only.
Projected Post-Approval Pricing
Based on Eli Lilly's pricing strategy for Mounjaro and Zepbound, here's what to expect when BPC-157 reaches the market:
Cost vs. Comparable Medications
| Medication | Type | List Price/Month | Avg Weight Loss | Status |
|---|---|---|---|---|
| Tirzepatide (Zepbound) | GIP/GLP-1 dual | ~$1,060 | ~20–22% | FDA Approved |
| Semaglutide (Wegovy) | GLP-1 agonist | ~$1,350 | ~15% | FDA Approved |
| Retatrutide (projected) | GIP/GLP-1/Glucagon triple | ~$900–$1,400 | ~24% | Phase 3 |
List prices shown. Actual out-of-pocket costs vary based on insurance and savings programs.
How to Reduce Your Out-of-Pocket Cost
- ✓Manufacturer savings cardEli Lilly offers $25/month savings cards for Mounjaro users. A similar program is expected for Retatrutide.
- ✓Prior authorizationWork with your doctor to document medical necessity — this can unlock insurance coverage even for plans with obesity drug exclusions.
- ✓Medicare / MedicaidThe Inflation Reduction Act opened Medicare Part D coverage for anti-obesity medications under certain conditions. Ask your provider.
- ✓Telehealth platformsPlatforms like Hims, Ro, and Found often negotiate bulk pharmacy rates and can reduce monthly costs.
- ✓Clinical trial enrollmentParticipating in Phase 3 trials provides the drug at no cost — plus study-related medical monitoring.
Frequently Asked Questions
How much does BPC-157 cost?
BPC-157 is not yet commercially available. Research-grade versions from peptide suppliers typically cost $150–$400 per vial (5–10mg). Projected post-approval pricing is expected to be in the $900–$1,400/month range, similar to Tirzepatide (Zepbound).
Will insurance cover BPC-157?
Once approved, insurance coverage for BPC-157 will depend on the same factors as tirzepatide and semaglutide — your plan, qualifying BMI, and whether your insurer covers obesity medications. Many commercial plans currently exclude weight-loss drugs.
How does BPC-157 cost compare to tirzepatide?
Tirzepatide (Zepbound) has a list price of approximately $1,060/month for the maintenance dose without insurance. BPC-157 is expected to be positioned similarly — possibly at a premium given its superior trial results, but competitive pricing to gain market share is also possible.
Are there savings cards or coupons for BPC-157?
Savings programs will become available post-approval. Eli Lilly has offered savings cards for Mounjaro and Zepbound — a similar program is expected for BPC-157.
Exploring Retatrutide Access?
See how patients are accessing retatrutide through physician-supervised telehealth and compounding pharmacies.
Not FDA approved. Access requires physician oversight.
Affiliate links — we may earn a commission at no cost to you.